BGI was established in 1999 with participation in the original Human Genome Project. Since then, BGI has grown in to one of the world’s largest genomics organisations, experienced in genomic research, commercial NGS services and sequencer manufacturing. We are committed to providing solutions to address the research, pharmaceutical, and clinical markets. Our focus has centered on improving human health and empowering large-scale plant and animal genomics research.
New Desktop System. Leveraging the proprietary sequencing technology
developed at Complete Genomics, BGI has announced a platform designed as
a desktop sequencer for deployment in China. This product is designed to
support a variety of sequencing applications.
World-Class NGS Service Capabilities. With regional service laboratories in the US, Europe and China, we offer a wide variety of human, plant, and animal NGS services to empower genomics research.
Committed to Quality. Our CAP-compliant and ISO certified laboratories offer both clinical-grade and research-use services to support our global clients with high-quality results and exceptional customer support.
+5,000 - employees, comprising laboratory technicians, administration, sales and marketing
+1,949 - publications in leading journals across the world
+82,745 - times our research has been cited
+1,100,00 - samples processed for research +4,900,00 - samples processed for clinical applications Countries
+100 - countries BGI operates in around the world
+18,000 - collaborators across the world
Building No. 7, BGI Park, No. 21 Hongan 3rd Street Yantian District, Shenzhen, 518083, China +86-755-25273698
BGI Americas, Cambridge, MA, USA BGI Europe, Copenhagen, Denmark BGI Asia Pacific, Hong Kong, China BGI Japan, Kobe, Japan